Cargando…
Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis
OBJECTIVE: To present the pooled quantitative evidence of baseline characteristics and clinical outcomes of tocilizumab (TCZ) in patients with refractory Takayasu arteritis (TAK). METHODS: A comprehensive systematic review and meta-analysis was performed on all available studies retrieved from the M...
Autores principales: | Kang, Limei, Liu, Yang, Luo, Zhongling, Zhou, Yueyuan, Chen, Bo, Yin, Geng, Xie, Qibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945188/ https://www.ncbi.nlm.nih.gov/pubmed/36845158 http://dx.doi.org/10.3389/fimmu.2023.1084558 |
Ejemplares similares
-
Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review
por: Li, Haiyan, et al.
Publicado: (2021) -
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
por: Prieto-Peña, Diana, et al.
Publicado: (2021) -
Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports
por: Asano, Tomoyuki, et al.
Publicado: (2020) -
Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022) -
Tertiary Lymphoid Organs in Takayasu Arteritis
por: Clement, Marc, et al.
Publicado: (2016)